Company: BGLC
Filing Date: 2025-03-25
Form Type: 8-K
Source: 0001477932-25-001958
Chunk: 1

Company: BioNexus Gene Lab Corp
Filing Date: 2025-03-25
Form: 8-K
Item: Item 5.07
Chunk 1
---
      1.25%                      
  ABSTAIN                9,308.73      < 1%                       

Result: Proposal 2 wasAPPROVED.

The final voting results were certified by the Inspector of Elections. No other matters were presented for a vote at the Meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BioNexus Gene Lab Corp.

             /s/ Su-Leng Tan Lee      
  By:        Su-Leng Tan Lee          
             Chief Executive Officer  
  Date:      March 25, 2025           

   3